Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation × Endocrine × 30 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 29 Pheochromocytoma 12 Paraganglioma 8 Adenoma, Islet Cell 8 Neoplasm Metastasis 7 Adrenocortical Carcinoma 7 Thyroid Neoplasms 6 Thyroid Cancer, Papillary 6 Pituitary Neoplasms 6 Melanoma 6 Colorectal Neoplasms 6 Carcinoma, Neuroendocrine 6 Adrenal Gland Neoplasms 6 Neoplasms 5 Multiple Endocrine Neoplasia Type 1 5 Breast Neoplasms 5 Pituitary ACTH Hypersecretion 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Differentiated Thyroid Cancer 4 Carcinoma, Renal Cell 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Hepatocellular 4 von Hippel-Lindau Disease 3 Somatostatinoma 3 Sarcoma 3 Prostatic Neoplasms 3 Pituitary Diseases 3 Parathyroid Neoplasms 3 Neuroblastoma 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡